Meeting
2020 ASCO Virtual Scientific Program
Population-based prostate cancer screening using a prospective, blinded, paired screen-positive comparison of PSA and fast MRI: The IP1-PROSTAGRAM study.
Authors
David Eldred-Evans
Imperial Prostate, London, United Kingdom
David Eldred-Evans , Paula Burak , Martin John Connor , Emily Day , Martin Evans , Francesca Fiorentino , Martin Gammon , Feargus Hosking-Jervis , Natalia Klimowska- Nassar , William McGuire , Anwar R Padhani , Derek Price , Toby Prevost , Heminder Sokhi , Henry Tam , Mathias Winkler , Hashim Uddin Ahmed
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
NCT03702439
Citation
J Clin Oncol 38: 2020 (suppl; abstr 5513)
DOI
10.1200/JCO.2020.38.15_suppl.5513
Abstract #
5513
Poster Bd #
94
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Rapid quantification of prostate specific antigen (PSA) from fingerstick (FS) blood.
First Author: Joseph Earl Thomas
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of multiparametric magnetic resonance imaging findings with oncologic outcomes in non-palpable localized prostate cancer.
First Author: Abhishek Kumar
Poster
2023 ASCO Annual Meeting
The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort.
First Author: Jan Oldenburg
Poster
2023 ASCO Genitourinary Cancers Symposium
Disparities in prostate cancer diagnoses in persons experiencing homelessness.
First Author: Zachary S Mayo